publication venue for
- Proton-pump inhibitors and survival outcomes in patients with metastatic renal cell carcinoma 2016
- Diagnostic accuracy of prostate imaging reporting and data system (PI-RADS) magnetic resonance score by assessing correlation to radical prostatectomy pathology findings 2016
- Contribution of Anti-GRP78 autoantibodies to prostate cancer progression through tissue factor procoagulant activity 2015
- Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer. 2024
- Radiological features characterising indeterminate testes masses: a systematic review and meta‐analysis. 131:288-300. 2023
- What are the benefits and harms of surgical management options for adult‐acquired buried penis? A systematic review. 131:8-19. 2023
- Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration. 128:607-614. 2021
- Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer. 126:433-435. 2020
- How long is long enough for pharmacological thromboprophylaxis in urology?. 124:902-904. 2019
- The impact of bariatric surgery on urinary incontinence: a systematic review and meta‐analysis. 124:917-934. 2019
- Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment‐naïve patients: a diagnostic test accuracy systematic review and meta‐analysis. 124:209-220. 2019
- Use of machine learning to predict early biochemical recurrence after robot‐assisted prostatectomy. 123:51-57. 2019
- α‐Blockers for uncomplicated ureteric stones: a clinical practice guideline. 122:924-931. 2018
- The challenge with systematic reviews of non‐randomised studies in urology. 121:161-162. 2018
- Understanding pain and coping in women with interstitial cystitis/bladder pain syndrome. 120:286-292. 2017
-
Systematic review of the oncological and functional outcomes of pelvic organ‐preserving radical cystectomy (
RC ) compared with standardRC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. 120:12-24. 2017 -
Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (
PD )‐1 orPD ligand 1 inhibitor therapy. 119:579-584. 2017 - Guideline of guidelines: thromboprophylaxis for urological surgery. 118:351-358. 2016
- Defining the publication source of high‐quality evidence in urology: an analysis of EvidenceUpdates. 117:861-866. 2016
- Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10‐year population‐based analysis. 117:954-960. 2016
- Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma. 115:854-855. 2015
-
Radiographic progression by Prostate Cancer Working Group (
PCWG )‐2 criteria as an intermediate endpoint for drug development in metastatic castration‐resistant prostate cancer. 114:E25-E31. 2014 - A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma. 113:E137-E143. 2014
- Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration. 112:791-797. 2013
- Disability in women suffering from interstitial cystitis/bladder pain syndrome. 111:114-121. 2013
- Ability of C‐reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel‐based chemotherapy. 110:E461-E468. 2012
- Single‐session primary high‐intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation‐based technology. 110:1142-1148. 2012
- Training in ureteroscopy: a critical appraisal of the literature. 108:805-805. 2011
- Evidence-based urology in practice: loss to follow-up. 106:24-26. 2010
- Laparoscopic right donor nephrectomy. 103:998-1013. 2009
- Chemosensitization of gemcitabine‐resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti‐apoptotic gene, clusterin. 103:384-390. 2009
- Clusterin knockdown using the antisense oligonucleotide OGX‐011 re‐sensitizes docetaxel‐refractory prostate cancer PC‐3 cells to chemotherapy. 102:389-397. 2008
- Paclitaxel and cisplatin as intravesical agents against non‐muscle‐invasive bladder cancer. 101:1347-1355. 2008
- Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. 101:59-64. 2008
- Severe bladder trabeculation obviates the need for bladder outlet procedures during augmentation cystoplasty in incontinent patients with neurogenic bladder. 101:223-226. 2008
- Clinical outcome following post‐chemotherapy retroperitoneal lymph node dissection in men with intermediate‐ and poor‐risk nonseminomatous germ cell tumour. 99:993-997. 2007
- SURGICAL MANAGEMENT OF PENILE CARCINOMA: THE PRIMARY LESION. 98:917-918. 2006
- Seminal plasma magnesium and premature ejaculation: a case-control study.. 98:402-404. 2006
- The role of indirect radionuclide cystography during the acute phase of pyelonephritis in young women. 95:619-623. 2005
- Comparison of modified one‐ and two‐layer microsurgical vasovasostomy. 87:278-278. 2001
- Comparison of modified one‐ and two‐layer microsurgical vasovasostomy. 85:1085-1088. 2000
- Renal cell carcinoma in a pelvic kidney. 83:514-514. 1999
- Primary neurilemmoma of the bladder. 79:132-133. 1997
- Ultrasonographic evaluation and clinical correlation of intratesticular lesions: a series of 39 cases. 76:216-219. 1995
- The wider spectrum of megalourethra. 75:563-563. 1995